India has ushered in a transformative phase in its intellectual property regime with the release of the 2025 Guidelines for the Examination of Computer-Related Inventions (CRIs). Issued by the Office of the Controller General of Patents, Designs & Trademarks (CGPDTM) on July 29, 2025, these guidelines mark a significant evolution in how software and artificial […]
Calcutta High Court Overturns Patent Rejection: Clarifies Standards for Morality and Public Health Exclusions
The Calcutta High Court’s judgment, in ITC Limited v. The Controller General of Patents Designs and Trademarks (IPDPTA/13/2024) marked a crucial development in Indian patent law by overturning the rejection of ITC’s patent application (No. 685/KOL/2015) for “a device and method to generate and deliver a nicotine aerosol”. The case centered on Section 3(b) of […]
INDIA- JUDICIAL CLARIFICATION ON SECTION 3(e) VS SECTION 3(d)- ORAMED LTD. vs THE CONTROLLER GENERAL OF PATENTS AND DESIGNS
In a recent ruling concerning pharmaceutical patents, the Calcutta High Court set aside a decision by the Controller of Patents for erroneously conflating the distinct legal standards for patentability of an invention. The judgment underscores ongoing concerns regarding inconsistencies in the examination of pharmaceutical composition claims, particularly where the statutory criteria are misapplied. Facts: The […]
Key Highlights of the Draft Patent (Amendment) Rules, 2025
On 18 July 2025, the Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, Government of India, published the Draft Patent (Amendment) Rules, 2025 in the Official Gazette. These proposed amendments aim to operationalize the changes introduced by the Jan Vishwas (Amendment of Provisions) Act, 2023, which seeks to decriminalize […]
Delhi High Court rejects Salmonella patent despite approval by USPTO and EPO
In Regents of the University of California (the ‘Appellant’) vs Controller of Patents and Designs (the ‘Respondent’) [C.A.(COMM.IPD-PAT) 481/2022], the Delhi High Court upheld the rejection of a patent application for genetically modified salmonella vaccine due to insufficient disclosure and overly broad claims, non-patentable subject matter, and failure to deposit recombinant microorganism as required under […]
The microRNA discovery: Singapore and Philippine patent applications
With the selection of the 2025 Nobel Prize laureate(s) in Physiology or Medicine (NPPM) now in the evaluation phase, it is worth revisiting 2024’s winners and ruminating the impact their discovery has had on patent applications filed in Singapore and the Philippines. The 2024 NPPM was jointly awarded to scientists Victor Ambros and Gary Ruvkun […]
EP patent validation in Laos
Following the Validation Agreement signed between the Laos Department of Intellectual Property (‘DIP’) and the European Patent Office (‘EPO’), European patent holders can now extend their patent protection to Laos without the need for a separate national application, effective 1 April 2025. This makes Laos the sixth country worldwide, and the second in Southeast Asia […]
Exploring the New Patent Playbook: Establishing a prima facie case before the issuance of a Notice for Pre-Grant Oppositions
Introduction In India Patent Application No. 202417006578, the Assistant Controller of Patents & Designs, issued an order in the context of a Pre-grant Opposition (‘PGO’) against Pharmazz Inc.’s said patent application. This decision is particularly notable as it represents the first application of a new rule requiring the establishment of a prima facie case before […]
Key Cases That Have Shaped IP Protection in Malaysia’s Fashion Industry
Several notable cases in Malaysia have significantly influenced the protection of intellectual property within the country’s fashion industry. Trade Mark In 2019, the High Court of Kuala Lumpur (“Court”) saw a heated trademark battle between fashion powerhouse 30 Maple Sdn Bhd (‘Plaintiff”) and individual seller Siti Safiyyah binti Mohd Firdaus Chew (“Defendant’). At the heart […]
Singapore – Expansion of IPOS’ Collaborative Search and Examination (CS&E) Programme with Indonesia
In addition to the existing CS&E programme with IP Viet Nam, IPOS has expanded its CS&E programme with the Directorate General of Intellectual Property (DGIP), Indonesia to expedite the prosecution process for parties who have an interest to pursue patent applications in both countries. This pilot programme was introduced on 2 January 2025 for 2 […]